Metropolitan Life Insurance Company (MetLife)’s Dorman Products DORM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,441	Closed	-$139K	–	612
2024 Q1	$139K	Sell	1,441 -76	-5%	-$6.55K	0.01%	881
2023 Q4	$127K	Hold	1,517	–	–	0.01%	958
2023 Q3	$115K	Buy	1,517 +53	+4%	+$4.31K	0.01%	934
2023 Q2	$115K	Hold	1,464	–	–	0.01%	946
2023 Q1	$126K	Sell	1,464 -162	-10%	-$14.4K	0.01%	882
2022 Q4	$131K	Buy	1,626 +78	+5%	+$6.62K	0.01%	919
2022 Q3	$127K	Hold	1,548	–	–	0.01%	881
2022 Q2	$170K	Sell	1,548 -107	-6%	-$10.6K	0.01%	780
2022 Q1	$157K	Sell	1,655 -5,253	-76%	-$509K	0.01%	938
2021 Q4	$781K	Sell	6,908 -135	-2%	-$14.7K	0.01%	1134
2021 Q3	$667K	Sell	7,043 -511	-7%	-$50.4K	0.01%	1253
2021 Q2	$783K	Buy	7,554 +478	+7%	+$49K	0.01%	1195
2021 Q1	$726K	Sell	7,076 -348	-5%	-$34.7K	0.01%	1174
2020 Q4	$645K	Sell	7,424 -547	-7%	-$50.7K	0.01%	1201
2020 Q3	$720K	Sell	7,971 -161	-2%	-$12.9K	0.01%	943
2020 Q2	$545K	Hold	8,132	–	–	0.01%	1138
2020 Q1	$449K	Sell	8,132 -403	-5%	-$27.4K	0.01%	1105
2019 Q4	$646K	Sell	8,535 -166	-2%	-$12.6K	0.01%	1175
2019 Q3	$692K	Buy	8,701 +550	+7%	+$42.7K	0.01%	1091
2019 Q2	$710K	Hold	8,151	–	–	0.01%	1090
2019 Q1	$718K	Sell	8,151 -840	-9%	-$73K	0.01%	1077
2018 Q4	$809K	Buy	8,991 +167	+2%	+$13.3K	0.02%	922
2018 Q3	$679K	Hold	8,824	–	–	0.01%	1160
2018 Q2	$603K	Hold	8,824	–	–	0.01%	1187
2018 Q1	$584K	Buy	8,824 +155	+2%	+$11K	0.01%	1174
2017 Q4	$530K	Sell	8,669 -9,700	-53%	-$658K	0.01%	1248
2017 Q3	$1.32M	Hold	18,369	–	–	0.01%	1112
2017 Q2	$1.52M	Hold	18,369	–	–	0.01%	1054
2017 Q1	$1.51M	Hold	18,369	–	–	0.01%	1061
2016 Q4	$1.34M	Sell	18,369 -408	-2%	-$27.9K	0.01%	1144
2016 Q3	$1.2M	Hold	18,777	–	–	0.01%	1186
2016 Q2	$1.07M	Hold	18,777	–	–	0.01%	1217
2016 Q1	$1.02M	Hold	18,777	–	–	0.01%	1166
2015 Q4	$891K	Hold	18,777	–	–	0.01%	1246
2015 Q3	$956K	Sell	18,777 -597	-3%	-$29.9K	0.01%	1213
2015 Q2	$923K	Sell	19,374 -1,009	-5%	-$49.2K	0.01%	1345
2015 Q1	$1.01M	Hold	20,383	–	–	0.01%	1184
2014 Q4	$984K	Hold	20,383	–	–	0.01%	1324
2014 Q3	$817K	Hold	20,383	–	–	0.01%	1403
2014 Q2	$1M	Buy	20,383 +507	+3%	+$27.7K	0.01%	1345
2014 Q1	$1.17M	Sell	19,876 -131	-0.7%	-$7.19K	0.01%	1234
2013 Q4	$1.12M	Buy	20,007 +188	+0.9%	+$9.45K	0.01%	1256
2013 Q3	$982K	Hold	19,819	–	–	0.01%	1289
2013 Q2	$904K	Buy	+19,819	New	+$824K	0.01%	1295

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s DORM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Dorman Products (DORM) in Q2 2024, closing a stake of 1,441 shares — an estimated $139K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DORM in Q2 2013 and held it in 44 quarters. The position peaked at $1.52M in Q2 2017. 264 funds tracked by Wall St. Rank hold DORM as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Dorman Products position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,441 Dorman Products shares in Q2 2024, an estimated $139K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Dorman Products in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Dorman Products position peaked at $1.52M in Q2 2017.
264 funds tracked by Wall St. Rank held Dorman Products as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.